Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2026)
Alpha Tau Medical (DRTS) posted Treasury Shares of $747506.0 for Q4 2025, down 38.28% sequentially from $1.2 million in Q2 2025, and down 12.87% YoY from $857899.0 in Q4 2024.
Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Treasury Shares for 6 years, with the latest figure at $747506.0 in Q4 2025.
- Quarterly Treasury Shares fell 12.87% year-over-year to $747506.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $747506.0 (down 12.87% YoY) and the FY2025 annual result came in at $747506.0, down 12.87% from the prior year.
- Treasury Shares declined to $747506.0 in Q4 2025 per DRTS's latest filing, from $1.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $13.7 million in Q4 2021 and troughed at $747506.0 in Q4 2025.
- A 5-year average of $2.8 million and a median of $924867.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2022: Treasury Shares jumped 90.03% in 2021, then plunged 93.27% in 2022.
- Over 5 years, Treasury Shares stood at $13.7 million in 2021, then slumped by 93.27% to $924867.0 in 2022, then decreased by 12.07% to $813268.0 in 2023, then grew by 5.49% to $857899.0 in 2024, then decreased by 12.87% to $747506.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $747506.0, $1.2 million, and $857899.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 810,165.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 810,165.00 |
| Jun 30, 2026 | 810,165.00 |
| Dec 31, 2025 | 747,506.00 |
| Dec 31, 2025 | 747,506.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Dec 31, 2024 | 857,899.00 |
| Dec 31, 2024 | 857,899.00 |
| Dec 31, 2023 | 813,268.00 |
| Dec 31, 2023 | 813,268.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Dec 31, 2022 | 924,867.00 |
| Dec 31, 2022 | 924,867.00 |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2020 | 7.23 Mn |
| Dec 31, 2020 | 7.23 Mn |